Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA)

Clinical trial NCT05232929 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05232929
Sponsor: Genentech, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Spinal Muscular Atrophy

Start date: 2022-03-29
Primary completion: 2026-12-31
Enrollment: 403

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.